Nifty

:

23962.80

Sensex

:

76741.82

80.75 (0.34%)
238.22 (0.31%)

Login

Nifty
Sensex

:
:

23962.80
76741.82

80.75 (0.34%)
238.22 (0.31%)

Fermenta Biotech Ltd.

Miscellaneous

Rating :

70/99

BSE: 506414 | NSE: FERMENTA

Watchlist

NSE BSE

401.65

09-Jul-2026

Open
High
Low
Previous Close

378
415
375.05
363.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2186102
885865698.15
415
248.85

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,180.48
16.45
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,248.02
0.93%
2.90

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.73
4.47
10.29

EBITDA CAGR (%)

10 Years
5 Years
3 Years

18.56
6.00
43.45

PAT CAGR (%)

10 Years
5 Years
3 Years

-
11.05
-

P:E (Median)

8 Years
5 Years
3 Years

10.24
9.89
7.79

P:BV (Average)

8 Years
5 Years
3 Years

2.59
2.14
2.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.82
16.68
17.27

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 109.88 122.04 -9.96% 114.24 146.25 -21.89% 107.12 89.54 19.63% 119.02 72.70 63.71%
Expenses 88.04 89.36 -1.48% 90.78 96.11 -5.55% 84.15 74.05 13.64% 96.49 70.89 36.11%
EBITDA 21.84 32.67 -33.15% 23.46 50.14 -53.21% 22.97 15.49 48.29% 22.53 1.81 1,144.75%
EBIDTM 19.88% 26.77% 20.54% 34.28% 21.44% 17.30% 18.93% 2.49%
Other Income 6.10 3.88 57.22% 3.43 2.22 54.50% 5.53 2.95 87.46% 8.84 2.63 236.12%
Interest 2.77 2.99 -7.36% 3.03 4.09 -25.92% 2.59 3.69 -29.81% 3.10 3.42 -9.36%
Depreciation 5.08 5.60 -9.29% 5.17 5.82 -11.17% 5.13 5.89 -12.90% 5.55 5.87 -5.45%
PBT 29.16 27.97 4.25% 16.59 42.45 -60.92% 20.77 8.86 134.42% 22.72 -4.85 -
Tax 7.59 -1.34 - 4.83 7.45 -35.17% 6.05 0.70 764.29% 6.48 0.00 0
PAT 21.57 29.31 -26.41% 11.76 35.00 -66.40% 14.72 8.16 80.39% 16.23 -4.85 -
PATM 19.63% 24.02% 10.29% 23.93% 13.74% 9.11% 13.64% -6.67%
EPS 7.34 9.97 -26.38% 4.00 11.90 -66.39% 5.01 2.77 80.87% 5.52 -1.65 -

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 121.58 139.85 -13.06% 137.36 156.47 -12.21% 130.22 95.03 37.03% 136.26 78.13 74.40%
Expenses 101.58 102.91 -1.29% 112.40 103.20 8.91% 103.59 76.25 35.86% 108.03 77.33 39.70%
EBITDA 20.00 36.94 -45.86% 24.96 53.27 -53.14% 26.64 18.78 41.85% 28.23 0.80 3,428.75%
EBIDTM 16.45% 26.42% 18.17% 34.05% 20.45% 19.76% 20.72% 1.03%
Other Income 5.06 3.89 30.08% 3.12 2.23 39.91% 5.43 2.88 88.54% 8.77 2.82 210.99%
Interest 2.82 2.99 -5.69% 3.04 4.08 -25.49% 2.58 3.69 -30.08% 3.10 3.43 -9.62%
Depreciation 5.11 5.87 -12.95% 5.37 6.08 -11.68% 5.40 6.15 -12.20% 5.81 6.12 -5.07%
PBT 26.21 31.98 -18.04% 17.48 45.34 -61.45% 24.08 11.82 103.72% 28.09 -5.93 -
Tax 7.61 -1.34 - 5.46 7.45 -26.71% 6.05 0.70 764.29% 6.48 0.00 0
PAT 18.60 33.32 -44.18% 12.02 37.89 -68.28% 18.03 11.12 62.14% 21.60 -5.93 -
PATM 15.30% 23.83% 8.75% 24.21% 13.85% 11.70% 15.85% -7.59%
EPS 6.69 11.79 -43.26% 4.39 12.66 -65.32% 6.49 3.92 65.56% 7.49 -2.01 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 450.26 430.53 307.09 328.91 387.96 372.82 300.51 404.67 12.51 5.52 6.13 Net Sales Growth 4.58% 40.20% -6.63% -15.22% 4.06% 24.06% -25.74% 3134.77% 126.63% -9.95% Cost Of Goods Sold 151.01 138.63 105.43 126.50 144.20 123.64 82.67 92.26 0.00 0.00 0.00 Gross Profit 299.25 291.90 201.66 202.42 243.77 249.18 217.83 312.42 12.51 5.52 6.13 GP Margin 66.46% 67.80% 65.67% 61.54% 62.83% 66.84% 72.49% 77.20% 100% 100% 100% Total Expenditure 359.46 330.76 269.76 289.93 311.25 278.20 231.94 276.88 23.78 14.06 12.79 Power & Fuel Cost - 27.23 19.78 18.24 20.35 14.23 12.74 13.88 2.47 1.54 0.80 % Of Sales - 6.32% 6.44% 5.55% 5.25% 3.82% 4.24% 3.43% 19.74% 27.90% 13.05% Employee Cost - 60.10 53.93 53.81 59.36 57.50 50.03 53.18 5.77 5.63 5.11 % Of Sales - 13.96% 17.56% 16.36% 15.30% 15.42% 16.65% 13.14% 46.12% 101.99% 83.36% Manufacturing Exp. - 40.92 33.48 31.59 34.43 29.83 21.52 27.60 3.13 1.96 1.07 % Of Sales - 9.50% 10.90% 9.60% 8.87% 8.00% 7.16% 6.82% 25.02% 35.51% 17.46% General & Admin Exp. - 41.28 41.36 41.26 35.60 26.90 32.84 27.69 2.83 3.80 3.71 % Of Sales - 9.59% 13.47% 12.54% 9.18% 7.22% 10.93% 6.84% 22.62% 68.84% 60.52% Selling & Distn. Exp. - 13.88 9.90 9.99 13.15 17.49 23.38 31.40 0.15 0.23 0.65 % Of Sales - 3.22% 3.22% 3.04% 3.39% 4.69% 7.78% 7.76% 1.20% 4.17% 10.60% Miscellaneous Exp. - 8.72 5.87 8.54 4.16 8.60 8.76 30.87 9.43 0.89 0.65 % Of Sales - 2.03% 1.91% 2.60% 1.07% 2.31% 2.92% 7.63% 75.38% 16.12% 23.82% EBITDA 90.80 99.77 37.33 38.98 76.71 94.62 68.57 127.79 -11.27 -8.54 -6.66 EBITDA Margin 20.17% 23.17% 12.16% 11.85% 19.77% 25.38% 22.82% 31.58% -90.09% -154.71% -108.65% Other Income 23.90 12.66 8.15 8.46 7.63 6.73 14.19 26.48 2.27 0.51 1.20 Interest 11.49 14.84 17.40 21.35 18.11 19.10 20.27 21.30 10.63 6.49 1.96 Depreciation 20.93 23.17 23.70 24.48 23.67 19.03 14.94 11.85 3.83 3.45 1.80 PBT 89.24 74.42 4.39 1.61 42.56 63.23 47.55 121.12 -23.46 -17.97 -9.21 Tax 24.95 6.80 14.14 -0.97 12.33 11.26 -16.12 10.77 0.69 0.33 -0.08 Tax Rate 27.96% 9.14% -306.72% 1.67% 28.97% 17.81% -33.90% 8.89% -2.94% -1.84% 0.87% PAT 64.28 67.62 -18.74 -57.00 30.24 51.97 63.67 110.35 -24.15 -18.30 -9.14 PAT before Minority Interest 64.28 67.62 -18.74 -57.00 30.24 51.97 63.67 110.35 -24.15 -18.30 -9.14 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 14.28% 15.71% -6.10% -17.33% 7.79% 13.94% 21.19% 27.27% -193.05% -331.52% -149.10% PAT Growth -4.94% - - - -41.81% -18.38% -42.30% - - - EPS 21.86 23.00 -6.37 -19.39 10.29 17.68 21.66 37.53 -8.21 -6.22 -3.11

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 525.42 469.48 335.66 349.94 398.52 377.29 292.95 404.67 302.67 164.13 154.80 Net Sales Growth 11.92% 39.87% -4.08% -12.19% 5.63% 28.79% -27.61% 33.70% 84.41% 6.03% Cost Of Goods Sold 186.94 147.40 130.13 153.55 153.15 134.37 79.02 92.26 80.41 68.43 64.51 Gross Profit 338.48 322.08 205.52 196.39 245.36 242.92 213.92 312.42 222.26 95.70 90.29 GP Margin 64.42% 68.60% 61.23% 56.12% 61.57% 64.39% 73.02% 77.20% 73.43% 58.31% 58.33% Total Expenditure 425.60 358.98 307.77 331.75 336.29 294.71 228.64 269.35 211.54 152.17 134.66 Power & Fuel Cost - 27.23 19.78 18.24 20.35 14.23 12.74 13.88 11.11 9.97 8.67 % Of Sales - 5.80% 5.89% 5.21% 5.11% 3.77% 4.35% 3.43% 3.67% 6.07% 5.60% Employee Cost - 65.10 58.55 58.00 62.97 58.22 50.03 53.18 39.83 30.84 27.97 % Of Sales - 13.87% 17.44% 16.57% 15.80% 15.43% 17.08% 13.14% 13.16% 18.79% 18.07% Manufacturing Exp. - 46.62 36.56 32.66 37.22 31.08 21.62 27.60 26.64 17.04 12.03 % Of Sales - 9.93% 10.89% 9.33% 9.34% 8.24% 7.38% 6.82% 8.80% 10.38% 7.77% General & Admin Exp. - 46.78 46.09 46.09 39.95 29.05 33.12 27.57 15.80 13.19 12.46 % Of Sales - 9.96% 13.73% 13.17% 10.02% 7.70% 11.31% 6.81% 5.22% 8.04% 8.05% Selling & Distn. Exp. - 17.47 11.36 13.97 17.06 19.13 23.38 31.40 26.90 5.47 5.71 % Of Sales - 3.72% 3.38% 3.99% 4.28% 5.07% 7.98% 7.76% 8.89% 3.33% 3.69% Miscellaneous Exp. - 8.37 5.30 9.24 5.58 8.63 8.73 23.47 10.84 7.23 5.71 % Of Sales - 1.78% 1.58% 2.64% 1.40% 2.29% 2.98% 5.80% 3.58% 4.41% 2.13% EBITDA 99.83 110.50 27.89 18.19 62.23 82.58 64.31 135.32 91.13 11.96 20.14 EBITDA Margin 19.00% 23.54% 8.31% 5.20% 15.62% 21.89% 21.95% 33.44% 30.11% 7.29% 13.01% Other Income 22.38 11.82 11.81 8.60 8.25 8.37 14.20 26.50 10.83 2.78 1.31 Interest 11.54 14.89 17.43 21.37 17.98 19.00 20.09 21.23 13.63 9.96 6.15 Depreciation 21.69 24.22 24.72 28.25 25.56 20.31 15.00 11.89 12.36 10.31 8.35 PBT 95.86 83.21 -2.45 -22.83 26.94 51.63 43.42 128.71 75.97 -5.53 6.96 Tax 25.60 6.80 14.14 1.83 11.88 9.10 -16.10 10.80 21.13 2.70 4.25 Tax Rate 26.71% 8.17% -143.12% -3.57% 44.10% 17.63% -37.08% 8.39% 27.81% -48.82% 61.06% PAT 70.25 76.86 -23.06 -51.07 15.45 45.51 59.53 117.88 42.21 -11.03 -0.59 PAT before Minority Interest 72.58 76.40 -24.01 -53.13 15.06 42.53 59.52 117.90 54.84 -8.23 2.71 Minority Interest 2.33 0.46 0.95 2.06 0.39 2.98 0.01 -0.02 -12.63 -2.80 -3.30 PAT Margin 13.37% 16.37% -6.87% -14.59% 3.88% 12.06% 20.32% 29.13% 13.95% -6.72% -0.38% PAT Growth -8.05% - - - -66.05% -23.55% -49.50% 179.27% - - EPS 23.89 26.14 -7.84 -17.37 5.26 15.48 20.25 40.10 14.36 -3.75 -0.20

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 379.95 314.23 336.06 395.97 370.45 312.60 249.49 64.72 89.61 82.64 Share Capital 14.58 14.44 14.43 14.42 14.42 14.42 4.59 2.29 2.29 2.29 Total Reserves 365.07 287.05 308.38 366.86 344.03 292.10 244.15 62.43 87.31 80.35 Non-Current Liabilities 29.24 77.08 97.34 158.41 135.31 73.40 125.39 139.79 37.53 15.20 Secured Loans 15.05 42.59 83.54 114.68 110.44 101.79 135.21 132.02 34.26 14.15 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 21.61 14.97 20.08 67.33 58.67 4.06 6.31 0.72 0.75 0.35 Current Liabilities 231.75 181.70 233.34 207.38 213.58 185.51 156.78 18.09 18.49 51.66 Trade Payables 64.28 53.03 51.91 45.57 45.70 47.17 43.44 1.80 0.76 1.37 Other Current Liabilities 47.77 39.58 58.34 42.52 49.78 33.13 47.43 10.41 14.09 46.99 Short Term Borrowings 81.24 67.34 101.46 97.47 96.30 104.33 60.21 5.72 3.50 2.44 Short Term Provisions 38.46 21.75 21.63 21.82 21.79 0.88 5.70 0.16 0.13 0.85 Total Liabilities 640.94 573.01 666.74 761.76 719.34 571.51 531.66 222.60 145.63 149.50 Net Block 222.65 261.40 228.11 219.98 249.57 126.07 103.65 11.80 8.17 93.40 Gross Block 357.65 377.09 319.93 293.38 315.01 162.59 127.89 13.46 8.83 99.69 Accumulated Depreciation 135.00 115.70 91.82 73.40 65.44 36.52 24.24 1.66 0.66 6.19 Non Current Assets 287.11 313.97 392.69 425.79 390.64 289.06 226.21 217.51 136.80 136.52 Capital Work in Progress 15.91 1.62 45.02 34.57 56.91 70.77 21.58 0.00 1.30 0.58 Non Current Investment 3.69 3.63 12.57 12.99 12.95 71.86 74.58 107.40 29.76 39.86 Long Term Loans & Adv. 39.58 39.85 54.28 87.66 70.36 18.87 17.36 2.58 1.83 2.68 Other Non Current Assets 2.10 2.07 24.01 3.82 0.86 1.49 9.04 11.64 10.26 0.00 Current Assets 353.84 259.04 274.04 335.97 328.69 282.46 295.26 5.09 8.82 12.98 Current Investments 0.00 0.00 2.78 0.00 0.00 0.00 1.15 1.06 1.00 0.80 Inventories 94.48 78.61 109.75 129.58 132.79 113.54 87.67 0.00 0.00 0.00 Sundry Debtors 120.21 77.13 67.41 117.83 96.12 77.44 65.60 0.28 0.39 0.03 Cash & Bank 61.95 56.64 55.11 30.75 41.30 32.37 90.73 1.57 0.96 3.00 Other Current Assets 77.20 7.92 4.12 15.65 58.47 59.10 50.12 2.18 6.47 9.15 Short Term Loans & Adv. 59.50 38.75 34.87 42.17 41.48 43.40 31.13 0.70 6.02 6.66 Net Current Assets 122.09 77.34 40.70 128.59 115.11 96.95 138.48 -13.00 -9.66 -38.68 Total Assets 640.95 573.01 666.73 761.76 719.33 571.52 531.66 222.60 145.62 149.50

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 362.67 288.86 315.31 372.13 360.59 309.44 250.55 124.45 144.40 129.82 Share Capital 14.58 14.44 14.43 14.42 14.42 14.42 4.59 2.29 2.29 2.29 Total Reserves 347.79 261.69 287.63 343.02 334.17 288.94 245.21 122.16 142.11 127.53 Non-Current Liabilities 29.24 77.03 97.43 154.05 131.41 71.52 125.39 145.65 48.11 24.27 Secured Loans 15.05 42.54 83.59 114.68 110.44 101.79 135.21 135.37 40.32 17.78 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 21.61 14.97 20.08 67.43 58.77 4.06 6.31 2.73 2.67 1.79 Current Liabilities 245.20 194.07 229.77 227.85 230.09 194.60 155.98 103.56 86.16 108.48 Trade Payables 77.49 64.90 45.79 64.58 62.14 56.33 42.72 40.09 27.49 19.77 Other Current Liabilities 47.84 39.61 58.53 43.72 49.90 33.12 47.42 29.38 20.79 56.62 Short Term Borrowings 81.24 67.34 101.46 97.47 96.30 104.33 60.21 29.86 37.13 29.34 Short Term Provisions 38.63 22.22 23.98 22.07 21.75 0.81 5.63 4.23 0.75 2.75 Total Liabilities 632.95 556.26 639.76 753.35 721.79 575.57 531.94 384.64 307.14 288.24 Net Block 223.37 263.13 238.25 231.31 262.93 128.89 103.73 96.88 89.81 168.10 Gross Block 367.61 387.06 338.52 308.92 330.73 166.48 128.99 114.18 103.03 221.97 Accumulated Depreciation 144.25 123.93 100.27 77.61 67.80 37.59 25.25 17.30 13.21 53.77 Non Current Assets 264.40 293.70 365.69 418.61 391.42 291.56 226.13 202.38 202.88 194.84 Capital Work in Progress 15.91 1.62 45.02 34.56 56.91 70.77 21.58 3.50 5.49 5.94 Non Current Investment 0.49 0.43 0.37 0.29 0.25 71.52 74.41 1.32 7.93 14.60 Long Term Loans & Adv. 19.36 21.05 29.33 81.35 70.47 19.60 18.64 6.80 4.51 6.20 Other Non Current Assets 2.10 2.07 24.01 3.82 0.86 0.78 7.77 13.39 13.31 0.01 Current Assets 368.55 262.57 274.07 334.74 330.38 284.01 295.61 182.27 104.26 93.40 Current Investments 0.00 0.00 2.78 0.00 0.00 0.00 1.15 1.06 1.00 0.80 Inventories 123.65 87.38 130.14 159.48 162.27 128.58 87.67 51.18 38.91 27.97 Sundry Debtors 95.23 69.83 41.65 87.09 68.01 69.77 65.54 68.72 44.57 43.01 Cash & Bank 71.70 59.83 58.33 33.61 44.53 33.11 91.13 32.66 2.49 4.79 Other Current Assets 77.98 6.55 4.08 11.25 55.56 52.55 50.12 28.65 17.28 16.84 Short Term Loans & Adv. 59.93 38.97 37.09 43.32 42.69 43.41 31.14 18.31 12.90 10.22 Net Current Assets 123.36 68.49 44.30 106.90 100.29 89.42 139.63 78.71 18.10 -15.08 Total Assets 632.95 556.27 639.76 753.35 721.80 575.57 531.93 384.65 307.14 288.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 33.83 105.02 123.75 50.41 62.96 29.83 90.51 1.32 -9.13 -4.97 PBT 74.42 -4.61 -57.98 42.56 63.23 47.55 121.12 -23.46 -17.97 -9.21 Adjustment 40.32 85.43 146.85 38.95 40.23 34.25 38.52 20.40 9.60 4.39 Changes in Working Capital -78.14 23.18 30.53 -21.83 -27.01 -38.05 -36.32 5.09 -2.10 0.67 Cash after chg. in Working capital 36.60 104.00 119.40 59.69 76.44 43.75 123.32 2.02 -10.47 -4.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.77 1.02 4.35 -9.28 -13.49 -13.91 -32.82 -0.70 1.35 -0.81 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 0.41 -15.15 -63.53 -32.46 -43.61 -39.19 -96.58 -88.99 19.64 -7.88 Net Fixed Assets 5.15 -13.76 -37.00 43.97 -138.56 -83.89 -136.01 -3.33 90.14 -15.75 Net Investments -0.06 11.72 -2.36 -0.04 58.91 3.87 32.73 -77.70 9.90 -0.61 Others -4.68 -13.11 -24.17 -76.39 36.04 40.83 6.70 -7.96 -80.40 8.48 Cash from Financing Activity -50.91 -90.86 -41.25 -21.76 -1.32 -47.63 12.22 88.31 -12.53 13.65 Net Cash Inflow / Outflow -16.67 -0.98 18.97 -3.81 18.03 -56.99 6.15 0.64 -2.01 0.80 Opening Cash & Equivalents 13.56 14.54 -4.49 -0.94 -18.96 38.02 31.87 0.71 2.72 2.19 Closing Cash & Equivalent -3.12 13.56 14.54 -4.75 -0.94 -18.96 38.02 1.35 0.71 3.00

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 40.90 105.35 116.11 43.44 62.60 34.46 90.34 59.26 1.91 4.44 PBT 83.21 -9.87 -51.31 26.94 51.63 43.42 128.71 75.97 -5.53 6.96 Adjustment 42.97 81.50 119.25 43.18 39.61 34.01 31.05 27.02 24.10 14.71 Changes in Working Capital -82.50 32.70 44.95 -17.38 -15.12 -29.03 -36.56 -25.46 -14.42 -14.47 Cash after chg. in Working capital 43.67 104.33 112.90 52.75 76.12 48.40 123.20 77.54 4.16 7.21 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -2.77 1.02 3.21 -9.31 -13.52 -13.94 -32.86 -18.28 -2.25 -2.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.16 -15.50 -55.41 -26.04 -41.55 -43.66 -96.58 -101.14 6.52 -13.38 Net Fixed Assets 5.15 -13.76 -37.00 43.97 -138.56 -83.89 -136.01 -3.33 90.14 -15.75 Net Investments -0.06 11.72 -2.36 -0.04 58.91 3.87 32.73 -77.70 9.90 -0.61 Others -5.25 -13.46 -16.05 -69.97 38.10 36.36 6.70 -20.11 -93.52 2.98 Cash from Financing Activity -50.87 -90.85 -41.38 -21.58 -1.14 -47.45 12.22 88.82 -12.11 10.42 Net Cash Inflow / Outflow -10.12 -1.00 19.32 -4.17 19.90 -56.65 5.99 46.93 -3.67 1.48 Opening Cash & Equivalents 16.75 17.75 -1.61 2.29 -18.22 38.42 32.44 -14.50 -10.82 3.30 Closing Cash & Equivalent 6.63 16.75 17.75 -1.88 2.29 -18.22 38.42 32.44 -14.50 4.79

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 130.16 104.42 111.86 132.17 124.26 106.26 86.69 23.52 32.56 30.03 ROA 11.14% -3.02% -7.98% 4.08% 8.05% 11.54% 29.26% -13.12% -12.40% -6.24% ROE 19.85% -6.00% -16.19% 8.18% 15.63% 23.36% 72.78% -31.30% -21.25% -10.44% ROCE 19.07% 2.56% -6.18% 9.85% 14.54% 13.83% 43.46% -7.52% -8.47% -5.46% Fixed Asset Turnover 1.17 0.88 1.07 1.28 1.56 2.07 5.73 1.12 0.10 0.10 Receivable days 83.65 85.90 102.78 100.64 84.96 86.87 29.71 9.76 13.86 5.98 Inventory Days 73.37 111.94 132.79 123.42 120.58 122.20 79.07 0.00 0.00 0.00 Payable days 154.43 181.65 140.63 115.51 137.08 79.96 34.73 30.19 30.05 43.28 Cash Conversion Cycle 2.59 16.19 94.95 108.55 68.46 129.11 74.05 -20.43 -16.19 -37.30 Total Debt/Equity 0.29 0.44 0.67 0.62 0.64 0.72 0.87 2.21 0.49 0.66 Interest Cover 6.02 0.74 -1.72 3.35 4.31 3.35 6.69 -1.21 -1.77 -3.71

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 124.23 95.63 104.67 123.91 120.84 105.16 87.07 45.22 52.47 47.18 ROA 12.85% -4.01% -7.63% 2.04% 6.56% 10.75% 25.73% 15.85% -2.76% 0.99% ROE 23.93% -8.30% -16.11% 4.27% 13.05% 21.92% 64.77% 40.79% -6.00% 2.08% ROCE 21.97% 1.58% -5.25% 7.50% 12.62% 12.98% 40.16% 33.86% 1.96% 6.18% Fixed Asset Turnover 1.24 0.93 1.08 1.25 1.52 1.98 3.33 2.79 1.02 0.87 Receivable days 64.16 60.61 67.14 71.03 66.65 84.30 60.55 68.24 96.46 90.86 Inventory Days 82.04 118.27 151.04 147.34 140.69 134.72 62.62 54.27 73.67 57.38 Payable days 176.30 155.24 131.18 150.99 160.90 86.23 63.57 60.55 60.91 51.44 Cash Conversion Cycle -30.10 23.64 87.00 67.38 46.44 132.79 59.60 61.95 109.22 96.80 Total Debt/Equity 0.30 0.48 0.72 0.66 0.66 0.73 0.87 1.39 0.60 0.70 Interest Cover 6.59 0.43 -1.40 2.50 3.72 3.16 7.06 6.57 0.45 2.13

Top Investors:

fermenta biotech limited esop trust

rakesh kantilal shah

krishan premnarayen .

investor education and protection fund (iepf)

Annual Reports:

News Update:

Fermenta Biotech gets FSSAI’s approval for VITADEE Green
6th Jul 2026, 09:19 AM

It supports the broader national objective of addressing Vitamin D deficiency through food fortification, an area where regulators have increasingly favoured plant-based sources
Read More
Fermenta Biotech - Quarterly Results
27th May 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback